DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 118 filers reported holding DYNE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 4.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $249,312 | -34.1% | 27,825 | -17.3% | 0.00% | – |
| Q2 2023 | $378,529 | +38.5% | 33,647 | +41.9% | 0.00% | – |
| Q1 2023 | $273,208 | +28.2% | 23,716 | +28.9% | 0.00% | – |
| Q4 2022 | $213,176 | -7.7% | 18,393 | +1.3% | 0.00% | – |
| Q3 2022 | $231,000 | +86.3% | 18,162 | +0.8% | 0.00% | – |
| Q2 2022 | $124,000 | -20.5% | 18,015 | +10.6% | 0.00% | – |
| Q1 2022 | $156,000 | -23.5% | 16,286 | -5.3% | 0.00% | – |
| Q4 2021 | $204,000 | -11.3% | 17,204 | +21.3% | 0.00% | – |
| Q3 2021 | $230,000 | -0.4% | 14,182 | +28.9% | 0.00% | – |
| Q2 2021 | $231,000 | -84.6% | 11,006 | -88.6% | 0.00% | -100.0% |
| Q1 2021 | $1,502,000 | +92.3% | 96,717 | +160.0% | 0.00% | – |
| Q4 2020 | $781,000 | +123.1% | 37,197 | +114.4% | 0.00% | – |
| Q3 2020 | $350,000 | – | 17,352 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $19,891,505 | 30.79% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $44,363,675 | 23.76% |
| Atlas Venture Life Science Advisors, LLC | 9,885,449 | $88,573,623 | 13.72% |
| Logos Global Management LP | 2,180,000 | $19,532,800 | 2.61% |
| TCG Crossover Management, LLC | 1,650,150 | $14,785,344 | 2.18% |
| VR Adviser, LLC | 2,173,913 | $19,478,260 | 2.05% |
| Altium Capital Management LP | 315,000 | $2,822,400 | 1.47% |
| Vivo Capital, LLC | 1,035,136 | $9,274,819 | 1.02% |
| Octagon Capital Advisors LP | 692,945 | $6,208,787 | 0.95% |
| ACUTA CAPITAL PARTNERS, LLC | 146,500 | $1,312,640 | 0.88% |